| scholarly article | Q13442814 |
| P50 | author | Shaun M Eack | Q89456256 |
| Susan S Hogarty | Q115666418 | ||
| Matcheri S Keshavan | Q48067656 | ||
| P2093 | author name string | Jack R Cornelius | |
| Srihari S Bangalore | |||
| P2860 | cites work | Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia | Q48826531 |
| The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. | Q50651673 | ||
| Schizophrenia and co-occurring substance use disorder. | Q50695270 | ||
| Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomize | Q50777040 | ||
| Measuring emotional intelligence with the MSCEIT V2.0. | Q51020533 | ||
| A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. | Q51919476 | ||
| Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. | Q52038454 | ||
| An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. | Q52271086 | ||
| Cognitive Training for Supported Employment: 2-3 Year Outcomes of a Randomized Controlled Trial | Q22241866 | ||
| The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements | Q22242826 | ||
| A meta-analysis of cognitive remediation in schizophrenia | Q24631519 | ||
| Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial | Q28290677 | ||
| Stages and processes of self-change of smoking: toward an integrative model of change | Q29618719 | ||
| The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample | Q33641039 | ||
| Abstinent adolescent marijuana users show altered fMRI response during spatial working memory | Q33705355 | ||
| Neurocognitive functioning of individuals with schizophrenia: using and not using drugs | Q33762494 | ||
| A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes | Q34026120 | ||
| Cognitive enhancement as a treatment for drug addictions | Q34284329 | ||
| Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. | Q34347478 | ||
| Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior | Q34550645 | ||
| Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial | Q35019827 | ||
| Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria | Q35874170 | ||
| Social cognition in schizophrenia, Part 1: performance across phase of illness | Q36121548 | ||
| A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. | Q36723305 | ||
| A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders | Q36851621 | ||
| Cognitive remediation: a new generation of psychosocial interventions for people with schizophrenia | Q36930812 | ||
| A meta-analytic review of psychosocial interventions for substance use disorders | Q37058269 | ||
| Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients | Q37076307 | ||
| Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence | Q37130981 | ||
| Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances--systematic review and meta-analysis | Q37964895 | ||
| Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings | Q38124448 | ||
| Alcohol use and abuse in schizophrenia. A prospective community study | Q39281419 | ||
| Substance use disorders in schizophrenia--clinical implications of comorbidity | Q43145195 | ||
| Current research on co-occurring substance-use disorder in schizophrenia | Q43192288 | ||
| Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. | Q43990949 | ||
| The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization | Q46063436 | ||
| Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change | Q47195545 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 74-82 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Journal of Dual Diagnosis | Q15762795 |
| P1476 | title | Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study | |
| P478 | volume | 12 |
| Q92536189 | A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine |
| Q38940577 | Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle. |
| Q50543542 | Cognitive Enhancement to Improve Substance Abuse Outcomes in Persons With Co-Occurring Disorders. |
| Q93084016 | Neurocognition and social cognition training as treatments for violence and aggression in people with severe mental illness |
| Q47568854 | Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders |
| Q50232494 | Trauma, Technology, and Routine Outcome Measures |
Search more.